On Friday, the US Food and Drug Administration is holding its first hearing to assess the safety and efficacy of these CBD products.
« Its critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDAs regulatory oversight of these products, » he said.
